Purpose Treatment of malignant and nonmalignant hematologic diseases with
hematopoietic stem-cell transplantation (HSCT) was first described almost 60 years ago,
and its use has expanded significantly over the last 20 years. Whereas HSCT has become
the standard of care for many patients in developed countries, the significant economic
investment, infrastructure, and health care provider training that are required to provide such
a service have prohibited it from being widely adopted, particularly in developing countries …

INTRODUCTION While hematopoietic stem cell transplantation has become the standard of
care for many patients in developed countries, the significant economic investment,
infrastructure, and healthcare provider training that are required have impeded widespread
implementation in resource-constrained settings. We describe our experience in developing
a transplant program at Dhaka Medical College and Hospital (DMCH) in Bangladesh via a
partnership with health care providers at the Massachusetts General Hospital (MGH). In …